tiprankstipranks
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market

Compare Keros Therapeutics (KROS) vs. Competitors

362 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Keros Therapeutics
$11.20
$220.93M
8.71
-8.46%
5 Buy
3 Hold
0 Sell
Moderate Buy
Gyre Therapeutics
$6.81
$674.81M
125.48
1.37%
2 Buy
0 Hold
0 Sell
Moderate Buy
KalVista Pharmaceuticals
$19.39
$993.20M
-37.98
83.97%
7 Buy
0 Hold
0 Sell
Strong Buy
Palvella Therapeutics
$127.12
$1.82B
-28.23
539.76%
13 Buy
0 Hold
0 Sell
Strong Buy
Nurix Therapeutics
$16.03
$1.66B
-5.04
81.95%
11 Buy
0 Hold
0 Sell
Strong Buy
Bicara Therapeutics Inc.
$21.12
$1.38B
-6.67
108.08%
8 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KROS
Keros Therapeutics
11.21
-1.54
-12.05%
GYRE
Gyre Therapeutics
7.39
-0.33
-4.27%
KALV
KalVista Pharmaceuticals
19.39
7.44
62.26%
PVLA
Palvella Therapeutics
127.12
102.68
420.13%
NRIX
Nurix Therapeutics
16.03
6.18
62.74%
BCAX
Bicara Therapeutics Inc.
21.12
9.74
85.59%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts